Results 61 to 70 of about 3,778,288 (330)

Rankings Games [PDF]

open access: yesSSRN Electronic Journal, 2011
Research rankings based on publications and citations today dominate governance of academia. Yet they have unintended side effects on individual scholars and academic institutions and can be counterproductive. They induce a substitution of the taste for science by a taste for publication.
Frey, Bruno S, Osterloh, Margit
openaire   +3 more sources

Efficacy and Tolerability of Topotecan/Cyclophosphamide/Dinutuximab in Relapsed and Refractory High‐Risk Neuroblastoma: A Multi‐Institutional Retrospective Study

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Purpose Chemoimmunotherapy with irinotecan, temozolomide, and dinutuximab (I/T/DIN) has emerged as first‐line therapy for relapsed/refractory (r/r) high‐risk neuroblastoma (HRNB) in North America. Topotecan and cyclophosphamide (T/C) are often used in combination with dinutuximab in the setting of lack of response, progression, or incomplete ...
Benjamin J. Lerman   +17 more
wiley   +1 more source

Geometry of rank tests [PDF]

open access: yes, 2006
We study partitions of the symmetric group which have desirable geometric properties. The statistical tests defined by such partitions involve counting all permutations in the equivalence classes. These permutations are the linear extensions of partially
Morton, Jason   +4 more
core   +3 more sources

Clinical Course and Impact of Breaks in Therapy for Children With Relapsed/Refractory Solid Tumors

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Introduction Pediatric relapsed or refractory (R/R) solid tumors carry a dismal prognosis, and postrelapse patient experiences are not well described. We present postrelapse outcomes, including number of R/R events and subsequent therapy regimens.
Matthew T. McEvoy   +5 more
wiley   +1 more source

Equalities and inequalities for ranks of products of generalized inverses of two matrices and their applications

open access: yesJournal of Inequalities and Applications, 2016
A complex matrix X is called an { i , … , j } $\{i,\ldots, j\}$ -inverse of the complex matrix A, denoted by A ( i , … , j ) $A^{(i,\ldots, j)}$ , if it satisfies the ith, …, jth equations of the four matrix equations (i) A X A = A $AXA = A$ , (ii) X A X
Yongge Tian
doaj   +1 more source

Miscellaneous equalities for idempotent matrices with applications

open access: yesOpen Mathematics, 2020
This article brings together miscellaneous formulas and facts on matrix expressions that are composed by idempotent matrices in one place with cogent introduction and references for further study.
Tian Yongge
doaj   +1 more source

Criterion‐Related Validity of the Neuropsychological Quick Assessment for Screening Cognitive, Motor, and Behavioral Impairments in Patients With Pediatric Brain Tumors: An Observational Pilot Study

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Background Neuropsychological complications may impair the qualitative prognosis of patients with pediatric brain tumors. However, multifaceted evaluations cannot be conducted in all patients because they are time consuming and burdensome for patients.
Ami Tabata   +9 more
wiley   +1 more source

The Evaluation of Influence of Environmental Factors on Intellectual Safety of Oil and Gas Enterprises [PDF]

open access: yesProblemi Ekonomiki, 2018
The aim of the article is to study, generalize and evaluate factors of external environment of an enterprise that affect its intellectual capital, for the purpose of studying their impact on managing intellectual safety of enterprises in the oil and gas ...
Orlova Valentina K. , Puida Halia V.
doaj  

The Efficacy and Safety of Bevacizumab/Irinotecan/Temozolomide (BIT) for Relapsed/Refractory Neuroblastoma: The UK Children's Cancer and Leukaemia Group Experience

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Background Patients with high‐risk neuroblastoma who either are refractory to induction chemotherapy or relapse following multi‐modal treatment have a dismal prognosis. Based on data from the BEACON trial, since 2021 the UK national guidelines recommend bevacizumab, irinotecan, and temozolomide (BIT) for patients with relapsed/refractory ...
Thomas J. Jackson   +20 more
wiley   +1 more source

Home - About - Disclaimer - Privacy